Therapeuticsmd incorporated
TXMD 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面獲得最高評分，但股利評分未超過2分，若公司開始配息，可能會有更優異的投資結果
TXMD 近期報酬表現
-0.53%
Therapeuticsmd incorporated
-0.10%
同產業平均
-1.57%
S&P500
與 TXMD 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
RPTX | Repare therapeutics inc | 3 分 | 1 分 | 2 分 | 2 分 | 1 分 | |
SGMT | Sagimet biosciences inc | - | 2 分 | 2 分 | 1 分 | 1 分 | |
FTRE | Fortrea holdings inc | - | 3 分 | 3 分 | 3 分 | 1 分 | |
TSBX | Turnstone biologics corp | - | 2 分 | 2 分 | 1 分 | 1 分 | |
INDV | Indivior plc | - | 2 分 | 1 分 | - | 1 分 |
- RPTX Repare therapeutics inc價值 3 分趨勢 1 分波段 2 分籌碼 2 分股利 1 分查看更多
TXMD 公司資訊
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).